Skip to main content
. 2014 Dec 15;5(1):411–422.

Table 4.

Toxicities caused by the two regimens

Toxicity and grade THP group DOX group P value

(n=47) (n=49)
Hematological toxicities
    Leucopenia
        All 42 (89.4%) 46 (93.9%) 0.334
        3 12 (25.5%) 16 (32.7%) 0.294
        4 5 (10.6%) 7 (14.3%) 0.410
    Anemia
        All 25 (53.2%) 29 (59.2%) 0.350
        3 3 (6.4%) 5 (10.2%) 0.381
    Thrombocytopenia
        All 22 (46.8%) 26 (53.1%) 0.341
        3 2 (4.2%) 3 (6.1%) 0.520
Nausea and vomiting
        All 24 (51.1%) 39 (79.6%) 0.003
        3-4 9 (19.1%) 20 (40.8%) 0.018
Hepatic dysfunction
        All 24 (51.1%) 27 (55.1%) 0.424
        3-4 9 (19.1%) 10 (20.4%) 0.541
Renal dysfunction
        1-2 3 (6.4%) 4 (8.2%) 0.524
Alopecia
        1-2 30 (63.8%) 42 (85.7%) 0.012
Mucositis
        All 23 (48.9%) 38 (75.6%) 0.003
        3-4 1 (2.1%) 5 (10.2%) 0.112
Cardiac toxicities
    Arrhythmia
        1-2 3 (6.4%) 9 (18.4%) 0.070
    Heart failure
        1-2 0 (0%) 2 (4.1%) 0.258
    Myocardial ischemia
        1-2 0 (0%) 3 (6.1%) 0.129
Infection
        1-3 2 (4.2%) 4 (8.2%) 0.359

Categorical data are presented as numbers (percentages). Differences were analyzed by Fisher’s exact test or χ2 test according to the data distribution.